Brief: Heidelberg Pharma And Advanced Proteome Therapeutics Progress Collaborative Program
08/01/2018 17:03
Jan 8 (Reuters) - HEIDELBERG PHARMA AG WL6G.DE :
* DGAP-NEWS: HEIDELBERG PHARMA AG AND ADVANCED PROTEOME
THERAPEUTICS PROGRESS COLLABORATIVE PROGRAM
Source text for Eikon: ID:nEQ122G8sa
Further company coverage: WL6G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty